TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,707.97+0.63%Nasdaq 10029,621.72+1.49%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$218.24+1.92%NYSE:TSM$423.54+2.65%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,142.05−0.56%Brent$109.46−0.32%BTC$81,913.26−0.12%ETH$2,398.95−0.35%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,707.97+0.63%Nasdaq 10029,621.72+1.49%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$218.24+1.92%NYSE:TSM$423.54+2.65%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,142.05−0.56%Brent$109.46−0.32%BTC$81,913.26−0.12%ETH$2,398.95−0.35%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Open 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

BioMarin Pharmaceutical Inc · Overview · TradingHolo

Markets › United States › NAS › BMRN

B

BioMarin Pharmaceutical Inc

NAS:BMRNHealthcareNASDAQ:NBISTOXX:EDD24BP

$54.68−2.44%At closeAt close · Sat 17 Oct · ≈ AED 200.81 · Market cap $10.58B · Next earnings Mon 26 Oct

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−2.4%

1M

−16.0%

3M

−7.5%

6M

+0.1%

1Y

+3.0%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

BMRN −2.44% today

✦ This week in three lines

No written digest yet for BMRN. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +11.6%

Valuation

P/E vs sector30.3× vs −1.7×

Price / Book vs sector1.7× vs 2.0×

Price / Sales vs sector3.3× vs 4.0×

Price / Free cash flow vs sector14.6× vs −1.6×

cheap for itself (18.4×)expensive for itself (167.1×)

Forecasts

24 buy7 hold0 sell31 analysts

Average target$96.22 +76.0%

Analysts9

EPS surprises, last 85 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All BMRN news →

DOBioMarin Pharmaceutical Price Target Cut to $88.00/Share From $114.00 by UBS

Dow Jones Newswires · 4 d ago

DOBioMarin Pharmaceutical Price Target Raised to $114.00/Share From $111.00 by Barclays

Dow Jones Newswires · 5 d ago

SEBioMarin Q3 financial results to see IPR&D expense impact of $283M

Seeking Alpha · 13 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$10.58B

P/E30.3×

Dividend yield0.0%

52-week range$49.26 – $70.98

Avg volume (20d)2,275,428

Shares outstanding193,574,000

Beta0.23

Short interest6.0% of float

Next earningsMon 26 Oct

Radar Score

62

Value62

Quality83

Momentum57

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%